Sam Chun Dang Pharm. Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.030x

Sam Chun Dang Pharm. Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Sam Chun Dang Pharm. Co. Ltd (000250) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩12.04 Billion ≈ $8.16 Million USD) by net assets (₩400.79 Billion ≈ $271.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sam Chun Dang Pharm. Co. Ltd (2012–2025)

Cash flow conversion efficiency of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2025. This chart illustrates how Sam Chun Dang Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Sam Chun Dang Pharm. Co. Ltd stock price for real-time trading data and today's change.

Sam Chun Dang Pharm. Co. Ltd Cash Flow Conversion Ratio Explained

Sam Chun Dang Pharm. Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sam Chun Dang Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam Chun Dang Pharm. Co. Ltd ranked by their cash flow conversion efficiency. Also see Sam Chun Dang Pharm. Co. Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Shurgard Self Storage SA BR:SHUR	0.020x
OLAM GROUP LTD F:K25	N/A
NovaGold Resources Inc TO:NG	-0.005x
CarGurus NASDAQ:CARG	0.622x
Xiamen Bank Co Ltd SHG:601187	0.071x
Comet Holding AG SW:COTN	0.119x
Beam Therapeutics Inc NASDAQ:BEAM	-0.062x
Hong Ri Da Technology Co. Ltd. A SHE:301285	N/A

Annual Cash Flow Conversion Efficiency for Sam Chun Dang Pharm. Co. Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Sam Chun Dang Pharm. Co. Ltd from 2012 to 2025. Review Sam Chun Dang Pharm. Co. Ltd (000250) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩363.59 Billion ≈ $246.40 Million	₩9.79 Billion ≈ $6.64 Million	0.027x	-67.08%
2024-12-31	₩266.11 Billion ≈ $180.34 Million	₩21.77 Billion ≈ $14.75 Million	0.082x	+4.22%
2023-12-31	₩298.46 Billion ≈ $202.26 Million	₩23.43 Billion ≈ $15.88 Million	0.078x	+2.70%
2022-12-31	₩173.74 Billion ≈ $117.74 Million	₩13.28 Billion ≈ $9.00 Million	0.076x	+272.65%
2021-12-31	₩174.09 Billion ≈ $117.98 Million	₩-7.71 Billion ≈ $-5.22 Million	-0.044x	-354.23%
2020-12-31	₩186.63 Billion ≈ $126.47 Million	₩3.25 Billion ≈ $2.20 Million	0.017x	-91.02%
2019-12-31	₩157.87 Billion ≈ $106.99 Million	₩30.60 Billion ≈ $20.74 Million	0.194x	+15.00%
2018-12-31	₩148.52 Billion ≈ $100.65 Million	₩25.03 Billion ≈ $16.97 Million	0.169x	-8.68%
2017-12-31	₩141.34 Billion ≈ $95.78 Million	₩26.09 Billion ≈ $17.68 Million	0.185x	+30.05%
2016-12-31	₩125.17 Billion ≈ $84.82 Million	₩17.76 Billion ≈ $12.04 Million	0.142x	-6.45%
2015-12-31	₩114.32 Billion ≈ $77.47 Million	₩17.34 Billion ≈ $11.75 Million	0.152x	+8.38%
2014-12-31	₩139.68 Billion ≈ $94.66 Million	₩19.55 Billion ≈ $13.25 Million	0.140x	+4.69%
2013-12-31	₩119.23 Billion ≈ $80.80 Million	₩15.94 Billion ≈ $10.80 Million	0.134x	+622.90%
2012-12-31	₩86.63 Billion ≈ $58.71 Million	₩1.60 Billion ≈ $1.09 Million	0.018x	--

About Sam Chun Dang Pharm. Co. Ltd

KQ:000250 Korea Pharmaceuticals

Market Cap

$2.60 Billion

₩3.84 Trillion KRW

Market Cap Rank

#5195 Global

#106 in Korea

Share Price

₩179200.00

Change (1 day)

+5.60%

52-Week Range

₩126500.00 - ₩1000000.00

All Time High

₩1000000.00